Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Delivra Health Brands Inc V.DHB

Alternate Symbol(s):  DHBUF

Healthcare Cannabis
Delivra Health Brands Inc. is a Canada-based consumer packaged goods company. The Company provides products that help with pain, sleep, anxiety, and performance through its acquired brands LivRelief and Dream Water. It operates a portfolio of brands under its Consumer Division consisting of Dream Products Inc. and its associated subsidiaries, and Delivra Corp. and its associated subsidiaries. Dream Water produces convenient, travel-friendly, single-serving 2.5oz liquid sleep shots, sleep powder packets that consumers can take with or without water and gummies. Its LivRelief brand offers relief for conditions such as joint and muscle pain, nerve pain, varicose veins, wound healing, and sports performance. It has also added three new products to its portfolio of licensed infused products: Transdermal 1:1 Cream- 250mg CBD:250mg THC; Transdermal CBD Cream with Cooling - 500mg CBD, and Extra Strength Transdermal CBD Cream: 1200mg CBD.


TSXV:DHB - Post by User

Delivra Health Brands Inc
Bullboard Posts
User Avatar Image
(27)
•••
Comment by NEWBIEVESTORon Aug 20, 2018 7:53pm
86 Views
Post# 28489890

RE:RE:RE:RE:RE:RE:RE:Cut your losses, sell and buy BE

RE:RE:RE:RE:RE:RE:RE:Cut your losses, sell and buy BE
Rohzen80 wrote: Why are you pumping Be in Hvt?


i used to pump this stock a lot when it had a lot going for it I feel bad for you bagholders getting screwed by bad management trying to help you out.

JOE - Canopy alone will produce 590,000kg, the whole market is estimated to only be under 1,000,000kg. Many of these stocks will sky rocket then come crashing down when they can’t sell product. Look at Colorado for a glimpse of the future. In 2017 they grew 55% more pot then consumed. Canada will get there even faster with 104 LP’s before it’s even legal.

Other guy- $13 million is plenty for BE when your expansions are built on time and will start pumping out serious cash in 60 days.

oh yeah BE and Hexo just got picked for the Ontario suppliers list. Looks like both will go up tomorrow, didn’t see HVT on it.

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities